Table 1.
Property | PCM of BphPs | GFP-like FPs | Advantage (+) or Disadvantage (−) of BphPs vs. GFP-like FPs | Ref |
---|---|---|---|---|
Overall structure | Consists of two or three domains with common α/β fold topology linked via α-helixes; exists as monomer, dimer or oligomer | Consist of a single domain, rigid β-barrel formed by 11 β-sheets Exist as monomer, dimer, tetramer or oligomer | (+) Domain organization allow diverse strategies for protein engineering (+) Suitable for engineering of optogenetic tools |
4, 7, 28, 29, 32, 33, 39 |
Size of monomer subunit | PAS-GAF domains: 300–310 a.a. (35–38 kDa) PAS-GAF-PHY domains: 500–530 a.a. (55–60 kDa) | 210–240 a.a. (24–28 kDa) | (−) Potentially may affect proper localization or function of target proteins | |
Chromophore formation | Apoprotein autocatalytically and covalently incorporates BV as a chromophore | Protein folding followed by autocatalytic chromophore formation in presence of oxygen | (+) Does not require molecular oxygen, therefore, may form in anaerobic conditions (−) Require exogenous BV, whose concentration may vary in different cell types and tissues (−) Presence of HO may improve BV incorporation |
4, 6, 10–12, 50 |
Absorbance/Emission maxima | 630–750 nm/680–800 nm * | 355–635 nm/425–670 nm | (+) Expands GFP-like fluorescent protein palette into NIR region (+) Optimal for whole-body imaging of mammals |
2, 4, 10, 20, 23 |
Photo- convertion wavelength and energy | Red (660–690 nm): 0.05–0.1 J/cm2; Far-red (740–760 nm): 0.025–0.1 J/cm2 | Violet-cyan (380–490 nm): up to 180 J/cm2; Orange (560–580 nm): up to 1.6 J/cm2 | (+) Easier photoconversion in deep-tissue samples | 51–53 |
Quantum yield | Low | High | (−) Low brightness may limit single- molecule imaging applications | 10, 11, 20 |
Extinction coefficient | High | Moderate | (+) Optimal for optoacoustic imaging (+) Preferable FRET acceptors for red GFP-like FPs |
2, 11, 12, 23 |
The upper value of the emission maxima is estimated based on the BphP absorbance spectra.